Mengru Cao

1.2k total citations
33 papers, 882 citations indexed

About

Mengru Cao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mengru Cao has authored 33 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Mengru Cao's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Ferroptosis and cancer prognosis (4 papers). Mengru Cao is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Ferroptosis and cancer prognosis (4 papers). Mengru Cao collaborates with scholars based in China, United States and Japan. Mengru Cao's co-authors include Li Cai, Hailing Lu, Jing Hu, Qingwei Meng, Ying Xing, Kazuhiro Kitamura, Rintaro Noro, Akinobu Yoshimura, Akihiko Gemma and Hideaki Mizutani and has published in prestigious journals such as Biomaterials, Cancer Research and Oncogene.

In The Last Decade

Mengru Cao

31 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengru Cao China 17 613 302 223 112 79 33 882
Anuradha Kirtonia India 10 563 0.9× 284 0.9× 173 0.8× 106 0.9× 71 0.9× 12 904
Nermin Kahraman United States 16 686 1.1× 373 1.2× 151 0.7× 71 0.6× 90 1.1× 32 913
Jing‐Wen Bai China 17 572 0.9× 269 0.9× 308 1.4× 159 1.4× 44 0.6× 39 1.0k
Haolan Wang China 6 520 0.8× 192 0.6× 251 1.1× 124 1.1× 86 1.1× 9 861
Guangchun He China 15 478 0.8× 297 1.0× 323 1.4× 176 1.6× 92 1.2× 25 952
Yi-Chieh Yang Taiwan 15 650 1.1× 325 1.1× 165 0.7× 108 1.0× 68 0.9× 19 869
Sarah Sarkar United States 12 486 0.8× 268 0.9× 356 1.6× 137 1.2× 69 0.9× 13 980
Yidan Ren China 14 622 1.0× 307 1.0× 252 1.1× 121 1.1× 108 1.4× 23 1.0k
Mihail Buse Romania 8 511 0.8× 176 0.6× 180 0.8× 99 0.9× 71 0.9× 14 878
Nengming Lin China 19 569 0.9× 173 0.6× 221 1.0× 180 1.6× 72 0.9× 55 870

Countries citing papers authored by Mengru Cao

Since Specialization
Citations

This map shows the geographic impact of Mengru Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengru Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengru Cao more than expected).

Fields of papers citing papers by Mengru Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengru Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengru Cao. The network helps show where Mengru Cao may publish in the future.

Co-authorship network of co-authors of Mengru Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Mengru Cao. A scholar is included among the top collaborators of Mengru Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengru Cao. Mengru Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Zhang, Shuai, Mengru Cao, Yan Shi, et al.. (2022). TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA. International Journal of Biological Sciences. 18(7). 2962–2979. 20 indexed citations
5.
Huang, Jian, Ying Song, Mengru Cao, et al.. (2021). A feedback circuit comprising EHD1 and 14-3-3ζ sustains β-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer. Cancer Letters. 520. 12–25. 20 indexed citations
6.
Xing, Ying, Mengru Cao, Weina Fan, et al.. (2021). LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer. Frontiers in Cell and Developmental Biology. 9. 686975–686975. 7 indexed citations
7.
Song, Yang, Yan Shi, Weina Fan, et al.. (2020). Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy. Frontiers in Cell and Developmental Biology. 8. 550–550. 18 indexed citations
8.
9.
Cao, Mengru, Yingkai Liu, Hanwen Yuan, et al.. (2020). HPLC-Based Qualitative and Quantitative Analyses of Alkaloids in Chewable Areca Products from Different Geographic Regions. Journal of AOAC International. 103(5). 1400–1405. 9 indexed citations
10.
Huang, Jian, Xiuwen Lan, Ting Wang, et al.. (2019). Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC. Oncogene. 39(8). 1739–1755. 38 indexed citations
11.
Xiao, Di, Zhicheng Lü, Zhiren Wang, et al.. (2019). Synthesis, biological evaluation and anti-proliferative mechanism of fluorine-containing proguanil derivatives. Bioorganic & Medicinal Chemistry. 28(2). 115258–115258. 9 indexed citations
12.
Cao, Mengru, Hanwen Yuan, Muhammad Daniyal, et al.. (2019). Two new alkaloids isolated from traditional Chinese medicine Binglang the fruit of Areca catechu. Fitoterapia. 138. 104276–104276. 21 indexed citations
13.
Hu, Jing, Huijuan Zhang, Mengru Cao, et al.. (2018). Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma. Molecular Cancer Therapeutics. 17(10). 2156–2163. 36 indexed citations
14.
Zhang, Huijuan, Bing Han, Hailing Lu, et al.. (2018). USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma. Cancer Letters. 433. 186–198. 49 indexed citations
15.
Wang, Xiaoyuan, Hang Yin, Hongxia Zhang, et al.. (2018). NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers. Cell Death and Disease. 9(4). 418–418. 27 indexed citations
16.
Yuan, Hanwen, Mengru Cao, Qingling Xie, et al.. (2018). Determination of alkaloids and phenols in the chewable husk products of Areca catechu L. Using HPLC-UV and UHPLC-MS/MS. Journal of Liquid Chromatography & Related Technologies. 41(10). 612–620. 10 indexed citations
17.
Chen, Xuesong, Ying Jiang, Zheping Huang, et al.. (2016). miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin. Scientific Reports. 6(1). 19455–19455. 44 indexed citations
18.
Wu, Shuhong, Li Wang, Xiao Huang, et al.. (2014). Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380. Bioorganic & Medicinal Chemistry. 22(19). 5234–5240. 6 indexed citations
19.
Cao, Mengru, Yulian Li, Hailing Lu, et al.. (2014). miR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells. Journal of Cancer Research and Clinical Oncology. 140(10). 1661–1670. 29 indexed citations
20.
Cao, Mengru, Masahiro Seike, Chie Soeno, et al.. (2012). MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. International Journal of Oncology. 41(3). 869–875. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anuradha Kirtonia Breakdown of academic impact, for papers by Nermin Kahraman Breakdown of academic impact, for papers by Jing‐Wen Bai Breakdown of academic impact, for papers by Haolan Wang Breakdown of academic impact, for papers by Guangchun He Breakdown of academic impact, for papers by Yi-Chieh Yang Breakdown of academic impact, for papers by Sarah Sarkar Breakdown of academic impact, for papers by Yidan Ren Breakdown of academic impact, for papers by Mihail Buse Breakdown of academic impact, for papers by Nengming Lin
Rankless by CCL
2026